Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
Chemopreventive and adjuvant
therapeutic potential of pomegranate (Punica granatum) for human breast
cancer.
Kim ND, Mehta R, Yu W, Neeman I, Livney T,
Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R,
Ramachandran C, Rabi T, Kaplan B, Lansky E.
Department of
Pharmacy, Pusan National University, Korea.
Fresh organically
grown pomegranates (Punica granatum L.) of the Wonderful cultivar were
processed into three components: fermented juice, aqueous pericarp
extract and cold-pressed or supercritical CO2-extracted seed oil.
Exposure to additional solvents yielded polyphenol-rich fractions
('polyphenols') from each of the three components. Their actions, and of
the crude whole oil and crude fermented and unfermented juice
concentrate, were assessed in vitro for possible chemopreventive or
adjuvant therapeutic potential in human breast cancer. The ability to
effect a blockade of endogenous active estrogen biosynthesis was shown
by polyphenols from fermented juice, pericarp, and oil, which inhibited
aromatase activity by 60-80%. Fermented juice and pericarp polyphenols,
and whole seed oil, inhibited 17-beta-hydroxysteroid dehydrogenase Type
1 from 34 to 79%, at concentrations ranging from 100 to 1,000 microg/ml
according to seed oil >> fermented juice polyphenols > pericarp
polyphenols. In a yeast estrogen screen (YES) lyophilized fresh
pomegranate juice effected a 55% inhibition of the estrogenic activity
of 17-beta-estradiol; whereas the lyophilized juice by itself displayed
only minimal estrogenic action. Inhibition of cell lines by fermented
juice and pericarp polyphenols was according to estrogen-dependent
(MCF-7) >> estrogen-independent (MB-MDA-231) > normal human
breast epithelial cells (MCF-10A). In both MCF-7 and MB-MDA-231 cells,
fermented pomegranate juice polyphenols consistently showed about twice
the anti-proliferative effect as fresh pomegranate juice polyphenols.
Pomegranate seed oil effected 90% inhibition of proliferation of MCF-7
at 100 microg/ml medium, 75% inhibition of invasion of MCF-7 across a
Matrigel membrane at 10 microg/ml, and 54% apoptosis in MDA-MB-435
estrogen receptor negative metastatic human breast cancer cells at 50
microg/ml. In a murine mammary gland organ culture, fermented juice
polyphenols effected 47% inhibition of cancerous lesion formation
induced by the carcinogen 7,12-dimethylbenz[a]anthracene (DMBA). The
findings suggest that clinical trials to further assess chemopreventive
and adjuvant therapeutic applications of pomegranate in human breast
cancer may be warranted.
PMID: 12002340 [PubMed - indexed for
MEDLINE]
|